DIVIDEND - 8.50
Q4FY23 – Performance
Overall – OK
Margin hit as compared with QoQ
Although YoY result is good, OMP improved
Total R&D spend up 20% in YoY which is 5% of annual revenue
Chronic share up by 13% and 300 bps increased
YoY Rev at 5665Cr Vs 5223Cr 
8.4%
QoQ Rev at 5665Cr Vs 5730Cr 
1%
Year ended Rev: 22,473Cr Vs 21,623Cr 4%
YoY PAT at 521Cr vs 370Cr 40%
QoQ PAT at 521Cr Vs 807Cr 35%
Year ended PAT: 2832Cr Vs. 2546Cr 11%
Q4EPS at 6.51Rs vs 4.48Rs Vs.9.92Rs
Year ended EPS: 34.69 Vs. 31.17
